Fachliteratur

Abstracts

 

2011

1) Erovic BM, Robert Yeung, Justin W. Lee, Ananth Ravi, Christopher Yao, Danny Enepekides, Kevin M. Higgins. Volumetric changes of the anterolateral thigh free flap following adjuvant radiotherapy in total parotidectomy reconstruction. 55. Österreichischer HNO Kongress, 14. 09. bis 17. 09. 2011, Hofburg Wien.

2) Erovic BM, Michael J. Daly, Harley Chan, Sajendra Nithiananthan, David D. Pothier, Adrian L. James, Blake C. Papsin, Jeffrey H. Siewerdsen, Jonathan C. Irish. Utility and accuracy of intraoperative cone-beam CT and optical drill tracking for guidance of temporal bone surgery. 55. Österreichischer HNO Kongreß, 14. 09. bis 17. 09. 2011, Hofburg Wien. 

3) Brunner M, Erovic BM, Thurnher D. p16 Expression in minor salivary glands.  55. Österreichischer HNO Kongreß, 14. 09. bis 17. 09. 2011, Hofburg Wien. 

2010

3) G. Heiduschka, Erovic BM, U. Kotowski, H. Martinek, M. Grasl, D. Thurnher. Kombination von Resveratrol und Bestrahlung in Merkelzell Karzinomzellen. 54. Österreichischer HNO-Kongress der Österreichischen Gesellschaft für Hals-, Nasen- und Ohrenheilkunde, Kopf- und Halschirurgie, 15. bis 19. September 2010, Universität Mozarteum Salzburg

2009

4) M. Brunner, Erovic BM, G. Heiduschka, D. Thurnher. Expression von RCAS-1 in Plattenepithelkarzinomen des Kopf-Hals-Bereiches. 53. Österreichischer HNO Kongress 2009. – 13. September 2009 – Festspielhaus Bregenz

5) G. Heiduschka, Erovic BM, M. Brunner, H. Martinek, U. Kotowski, D. Thurnher. Die Hemmung des Hedgehogpathways in Kopf-Hals-Tumorzelllinien. 53. Österreichischer HNO Kongress 20099. – 13. September 2009 – Festspielhaus Bregenz

6)  D. Thurnher, Erovic BM, M. Brunner, G. Kornek, B. Bachtiary, C. Schopper, M. Burian.Die Prävalenz von high-risk HPV in einem ostösterreichischen Kopf- und Halstumorpatientenkollektiv. 53. Österreichischer HNO Kongress 20099. – 13. September 2009 – Festspielhaus Bregenz

7) M. Brunner, V. Zielinski, G. Heiduschka, Erovic BM, D. Thurnher. ADAM-8 im Serum von Patienten mit Plattenepithelkarzinomen des oberen Respirationstraktes. 53. Österreichischer HNO Kongress 2009. – 13. September 2009 – Festspielhaus Bregenz

8) U. Kotowski, M. Brunner, G. Heiduschka, C. Czembirek, C. Czembirek-Eder, Erovic BM, H. Martinek, D. Thurnher. Rapamycin als möglicher Chemosensitizer in Kopf-Hals Tumorzelllinien. 53. Österreichischer HNO Kongress 20099. – 13. September 2009 – Festspielhaus Bregenz.

9) C. Gedlicka, Erovic BM, G. Heiduschka, J. Bigenzahn, H. Martinek, D. Thurnher. Führen Benzpyrene zu p53 Mutationen in Plattenepithelkarzinomzelllinien und können diese durch Radikalfänger verhindert werden? 53. Österreichischer HNO Kongress 2009. – 13. September 2009 – Festspielhaus Bregenz

2008

10) Erovic BM, Brunner M, Grasl MC, Pammer J, Thurnher D. Multimodale therapie von Patienten mit kleinen Speicheldrüsenkarzinomen im HNO Bereich. 52. HNO-Kongress in Graz. 10. - 13. September 2008

2007

11) M. Brunner, Dietmar Thurnher, Johannes Pammer, Sylvana Geleff, Gregor Heiduschka, Erovic BM. Expression von VEGF-A/C, VEGF-R2, PDGF-α/β, c-kit, EGFR, Her-2/Neu, Mcl-1 und Bmi-1 in Merkelzellkarzinomen. 51. HNO-Kongress, Innsbruck 12.-15. September 2007.

12) M. Grasl, C. Arnoldner, M. Brunner, JS Hamzavi, D. Thurnher, Erovic BM. Nachblutungen nach Adenotonsillektomie: Eine Analyse von 9026 Operationen an der Wiener HNO Klinik. 51. HNO-Kongress, Innsbruck 12.-15. September 2007.

13) Christoph Arnoldner, Matthäus Ch. Grasl, Dietmar Thurnher, Jafar-Sasan Hamzavi, Markus Brunner, Erovic BM. Surgical revision of haemorrhage after 8388 cold steel adenotonsillectomies. 6th European Congress of Oto-Rhino-Laryngology Head and Neck Surgery June 30th - July 4th, 2007.

14) Brunner M, Thurnher D, Grasl MC, Arnoldner C, Erovic BM. Elevated levels of circulating endothelial progenitor cells in patients with head and neck squamous cell cancer. 5th International Symposium on Advances in Head and Neck Cancer – Recurrences, February 1-3 2007, Marburg, Germany.

15) Erovic BM, Brunner M, Grasl MC, Pammer J, Arnoldner C, Geleff S, Thurnher D.Expression of : Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma – is targeted anticancer therapy a feasible option? 5th International Symposium on Advances in Head and Neck Cancer – Recurrences, February 1-3 2007, Marburg, Germany

2005

16) Erovic BM, M. Pelzmann, MCh. Grasl, J. Pammer, GV. Kornek, W. Brannath, E. Selzer, D. Thurnher. Determination of Mcl-1, VEGF-R2 and 14-3-3s expression might predict primary response against radio (-chemo) therapy in patients with locally advanced squamous cell carcinomas of the head and neck. 4th Internation Symposium on Advances in Head and Neck Cancer, 19-22 January, 2005, Marburg, Germany

17) D. Thurnher, Erovic BM, K Krapfenbauer, D. Turhani. Identification of differentially expressed tumor-associated proteins in head and neck squamous cell carcinoma by using proteome analysis. 4th Internation Symposium on Advances in Head and Neck Cancer, 19-22 January, 2005, Marburg, Germany

18) MCh. Grasl, Erovic BM, E. Selzer, F. Frommlet, D. Thurnher. Long-term treatment results for T1a laryngeal squamous cell carcinoma of the glottic larynx: evidence for superiority of laser and conservative surgery over radiation therapy. 4th Internation Symposium on Advances in Head and Neck Cancer, 19-22 January, 2005, Marburg, Germany

19) C. Skoda, C. Czembirek, L. Vormittag, Erovic BM, H. Martinek, M. Brunner, V. Wachek, D. Thurnher. Transfektion von Mcl-1 Antisense –Oligonukleotid erhöht die Sensitivität von malignen Kopf-Halstumorzelllinien für Cisplatin. 49. Österreichischer HNO Kongress, 21-24 September 2005, Salzburg.

20) Erovic BM, C. Czembirek, L. Vormittag, CC. Zielinski, H. Martinek, M. Brunner, D. Thurnher. Das Genexpressionsprofil von malignen Kopf-Halstumorzelllinien nach Exposition mit Nimesulide, einem selektiven COX-2 Hemmer, und/oder Cisplatin. 49. Österreichischer HNO Kongress, 21-24 September 2005, Salzburg.

21) C. Czembirek, C. Eder-Czembirek, Erovic BM, A. Spittler, D. Thurnher, E. Selzer. Ist der Zusatz von Nimesulide, einem COX-2 Hemmer, zur konventionellen Strahlentherapie in Kopf-Halstumorzelllinien sinnvoll? 49. Österreichischer HNO Kongress, 21-24 September 2005, Salzburg.

22) L. Vormittag, Erovic BM, H. Martinek, G. Kornek, M. Brunner, D. Thurnher. Zytotoxizität von Cucurmin und Resveratrol in Kopf-Hals Tumorzelllinien. 49. Österreichischer HNO Kongress, 21-24 September 2005, Salzburg.

23) Eder-Czembirek C, Czembirek C, Heiduschka G, Vormittag L, Erovic BM, Thurnher D. Caroverin: Radikalfänger mit Anti-Tumoraktivität? 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

24) Skoda C, Vormittag L, Heiduschka G, Kloimstein P, Eder-Czembirek C, Czembirek C, Erovic BM, Martinek H, Wrba F, Selzer E, Thurnher D. Effekte der Mcl-1 Regulation bei der Behandlung von Kopf-Halstumorzelllinien mit verschiedenen zytotoxischen Substanzen. 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

25) Erovic BM, G. Mitulovic, S. Hallström, H. Martinek, M. Brunner, M. Woegerbauer, W. Brannath, K. Mechtler, D. Thurnher. Genom und Proteom Mapping von Nimesulide/Cisplatin induzierter Apoptose in Tumorzellen des oberen Respirationstraktes. 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

26) C. Gedlicka, Erovic BM, M.Ch. Grasl, H. Martinek, D. Thurnher. DNA Extraktion aus archivierten Parraffin-eingebetteten Gewebsproben: eine Möglichkeit zur Bestimmung von prediktiven Faktoren bei lokal fortgeschrittenen Kopf-Hals Tumoren. 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

27) H. Martinek, L. Vormittag, G. Heiduschka, M. Wögerbauer, I. Lechner, Erovic BM, D. Thurnher Definition neuer Resistenzgene in Plattenepithelkarzinomzelllinien des Kopf-Hals Bereiches. 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

28) M. Wögerbauer, I. Lechner, D. Thurnher, C. Neuchrist, Erovic BM. Posttranskriptionelle Regulation der CD9 Expression in Tumorzellen des Kopf-Hals Bereiches. 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

29) G. Heiduschka, L. Vormittag, Erovic BM, V. Wachek, H. Martinek, M. Brunner, W. Marik, K. Ehrenberger, D. Thurnher. Lipophiles 7-beta-Hydroxycholesterol induziert Apoptose in Plattenepithelkarzinomen des Kopf-Hals Bereiches. 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

30) C. Czembirek, C. Czembirek, L. Vormittag, H. Martinek, M. Brunner, C. Arnoldner, H. Sommer, W. Habermann, M. Cartellieri, W. Brannath, Erovic BM. Thurnher. Kann uns ein Gen-Expressions-Profil von noch unbehandelten Patienten mit fortgeschrittenen Kopf-Hals Tumoren das therapeutische Ansprechen auf eine bestimmte kombinierten Radiochemotherapie vorhersagen? Ein Zwischenbericht einer Multizenter Studie. 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

31) D. Thurnher, J. Pammer, H. Martinek, M. Brunner, M. Woegerbauer, P. Valent, Erovic BM. CD29 und Bmi-1, als potenzielle Stammzellmarker in oralen Keratinozyten. 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

32) L. Vormittag, Erovic BM, S. Geleff, W. Brannath, D. Thurnher. Popodoplanin – ein Biomarker für den Lymphknotenstatus bei Kopf-Hals Tumoren. 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

33) M. Brunner, Erovic BM, H. Martinek, C. Arnoldner, W. Marik, D. Thurnher. Zirkulierende Endothelvorläuferzellen als Biomarker bei Patienten mit fortgeschrittenen Plattenepithelkarzinomen im Kopf-Hals Bereich. 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

34) Philip Kloimstein, Erovic BM, Laurenz Vormittag, Dietmar Thurnher, Matthäus Ch. Grasl. Immunhistochemische Mcl-1 Expression in malignen Tumoren der Ohrspeicheldrüse. 50. HNO-Kongress, Klagenfurt 13.-17. September 2006.

2004

35) D. Thurnher, Erovic BM, L. Vormittag, H. Ulrich-Pur, Ch. Eder-Czembirek, K. Ehrenberger. The metabolite 7b-hydroxycholesterol induces apoptosis in malignant head and neck cancer cells and acts synergistically with cisplatin. 6th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, 25-29 January, 2004

36) Erovic BM, S. Kandutsch, M. Wögerbauer, F. Frommlet, E.Selzer, G. Kornek, C. Neuchrist, MCh. Grasl, D. Thurnher. Cyclooxygenase-1 is upregulated in squamous cell carcinomas of the head and neck. 7th International Symposium on Predictive Oncology and Intervention Strategies, 7-1   0th February, 2004, Nice, France.

37)  D. Thurnher, Erovic BM, L. Vormittag, H. Ulrich-Pur, Ch. Eder-Czembirek, K. Ehrenberger. The metabolite 7b-hydroxycholesterol induces apoptosis in malignant head and neck cancer cells and acts synergistically with cisplatin. 7th International Symposium on Predictive Oncology and Intervention Strategies, 7-10th February, 2004, Nice, France.

38) D. Thurnher, Erovic BM, E. Selzer, F. Frommlet, MCh. Grasl. Early glottic cancer (T1a): Comparison of primary radiotherapy, convential and laser surgery. 6th International Conference on Head and Cancer, 7-11 August 2004, Washington.

39)  D. Thurnher, Erovic BM, L. Vormittag, H. Ulrich-Pur, D. Turhani, Ch. Eder-Czembirek, K. Ehrenberger. The metabolite 7beta-hydroxycholesterol induces apoptosis in malignant head and neck cancer cells and acts synergistically with cisplatin. 6th International Conference on Head and Cancer, 7-11 August 2004, Washington.

40) Erovic BM, M. Pelzmann, MCh. Grasl, J. Pammer, G. Kornek, D. Thurnher. Mcl-1 expression in head and neck cancer patients can predict primary response to radiotherapy. 6th International Conference on Head and Cancer, 7-11 August 2004, Washington.

41)  Erovic BM, M. Wögerbauer, S. Kandutsch, F. Frommlet, E.Selzer, GV. Kornek, C. Neuchrist, MCh. Grasl, D. Thurnher. Cyclooxygenase-1 is upregulated in squamous cell carcinomas of the head and neck. 6th International Conference on Head and Cancer, 7-11 August 2004, Washington.

42) M. Woegerbauer, I. Lechner, C. Neuchrist, Erovic BM. Loss of CD9 on SCC tumor cells is caused by a switch from short to long mRNAs. Gemeinsame Jahrestagung 20.-22. September 2004, Innsbruck, OGBM, OGGGT, OGBT, ANGT

43) Erovic BM, M. Wögerbauer, S. Kandutsch, E.Selzer, G. Kornek, MCh. Grasl, D. Thurnher. Die Expression von Cyclooxygenase-1 ist in Plattenepithelkarzinomen des Kopf-Hals Bereiches erhöht. 48. Österreichischer HNO Kongress, 22.-25. September 2004, Linz.

44) Erovic BM, M. Pelzmann, MCh. Grasl, J. Pammer, G. Kornek, F. Frommlet, E.Selzer, D. Thurnher. Die Expression von Mcl-1 in Kopf-Hals Tumoren ermöglicht die Vorhersage eines Ansprechens auf eine primäre Radiochemotherapie. 48. Österreichischer HNO Kongress, 22.-25. September 2004, Linz.

45) D. Thurnher, Erovic BM, L. Vormittag, W. Lamm, Ch. Eder-Czembirek, C. Czembirek, K. Ehrenberger. Der Metabolit 7b-hydroxycholesterin induziert Apoptose in Kopf-Halstumorzelllinien und wirkt synergistisch mit Cisplatin. 48. Österreichischer HNO Kongress, 22.-25. September 2004, Linz.

46) L. Vormittag, W. Lamm, Erovic BM, C. Czembirek, G. Kornek, D. Thurnher. Expression von Akt in Kopf- und Halstumorzelllinien nach Behandlung mit Nimesulide. 48. Österreichischer HNO Kongress, 22.-25. September 2004, Linz.

47) W. Lamm, L. Vormittag, Erovic BM, C. Czembirek, C. Eder-Czembirek, D. Thurnher. Die Wirkung von Nimesulide, einem spezifischen Cyclooxygenase-2 Hemmer auf die Expression von Ets-1 und Ets-2 in Kopf-und Halstumoren. 48. Österreichischer HNO Kongress, 22.-25. September 2004, Linz.

48) C. Eder-Czembirek, C. Czembirek, Erovic BM, E. Selzer, D. Thurnher. Verbessert die Betulinsäuere die Cytotoxizität von Radio-/Chemotherapie in HNO Tumoren? 48. Österreichischer HNO Kongress, 22.-25. September 2004, Linz.

49) Erovic BM, J. Pammer, D. Hollemann, M. Woegerbauer, S. Geleff, M.B. Fischer, M. Burian, F. Frommlet, C. Neuchrist. Motility-Related Protein-1/CD9 expression in head and neck squamous cell carcinoma. 48. Österreichischer HNO Kongress, 22.-25. September 2004, Linz.

50) Ulrich-Pur H, Erovic BM, Soleiman A, Jech B, Pennwieser W, Czembirek C, Zielinski CC, Thurnher D. Changes in Mcl-1 Expression in Rectal Cancer in Dependence upon the Administration of Adjuvant Radiotherapy. 6th Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association, Waikoloa/Hawaii January 25-29, 2004.

2003

51) Erovic BM, C. Neuchrist, MCh. Grasl, C. Czembirek, D. Turhani, D. Thurnher. Cyclooxygenase-1 is upregulated in squamous cell carcinomas of the head and neck. VII. Symposion on Research in Head and Neck Cancer, 4-6 September 2003, Düsseldorf, Germany

52) D. Thurnher, Erovic BM, MCh. Grasl, E.Selzer, C. Eder-Czembirek, D. Turhani, C. Neuchrist. Mcl-1, but not CD9, might predict clinical outcome of patients with advanced head and neck cancer after concomitant radiochemotherapy. VII. Symposion on Research in Head and Neck Cancer, 4-6 September 2003, Düsseldorf, Germany

2002

53) Erovic BM, M. Pelzmann, D. Turhani, V. Niederberger, C. Neuchrist, M.Ch. Grasl, D. Thurnher. Expressionsmuster von Cox-1 und Cox-2 in Plattenepithelkarzinomen des oberen Aerodigestivtraktes. 46. Österreichischer HNO Kongress, 18-22 September 2002, Feldkirch

2001

54) Erovic BM, J. Pammer, D. Hollemann, M. Woegerbauer, MB. Fischer, M. Burian, C. Neuchrist. MRP-1/CD9 Expression in squamous cell carcinomas of the head and neck. 45. Österreichischer HNO Kongress, 12-15 September 2001, Graz.

2000

55) Erovic BM, M. Burian, A. Handisurya, C. Neuchrist. Vorkommen und Verteilung von Vascular Endothelial Growth Factor 3 in Plattenepithelkarzinomen des HNO Bereiches (HNSCC). 44. Österreichischer HNO Kongress, 13-16 September 2000, Wien.

1999

56) C. Neuchrist, Erovic BM, Ch. Quint, M. Burian. FLK-1 (VEGF Receptor 2) in Plattenepithelkarzinomen des HNO Bereiches. 43. Österreichischer HNO Kongress, 15-19 September 1999, Rust am Neusiedler See.


Editor in peer-reviewed Journalen

Journal of Skin Cancer


Publikationen in peer-reviewed journalen

 

2011

1) Erovic BM, Al Habeeb A, Harris L, Goldstein DP, Ghazarian D, Irish JC. Merkel cell polyomavirus (MCPyV) large T-antigen overexpression in Merkel cell carcinoma: A potential role for targeted therapy. Head Neck. Accepted.

2) Erovic BM, Kim D, Goldstein DP, Al Habeeb A, Waldron J, Ghazarian D, Irish JC. Sebaceous gland carcinoma: The Princess Margaret Hospital experience: Head Neck. Accepted

3) Schneider S, Thurnher D, Kloimstein P, Leitner V, Petzelbauer P, Pammer J, Brunner M, Erovic BM. Expression of the Sonic Hedgehog pathway in squamous cell carcinoma of the skin and mucosa of the head and neck. Head Neck. 2011;33:244-250.

4) Heiduschka G; Erovic BM, Pammer J, Kaider A; Grasl MCh, Thurnher D. Mcl-1 Expression is up-regulated in Malignancies of the Parotid Gland. Accepted Dis Markers March. 2011;30:229-233.

5) Zielinski V, Brunner M, Heiduschka G, Schneider S, Seemann R, Erovic B, Thurnher D. ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study. BMC Cancer. Accepted June 2011.

2010

6) Erovic BM, Schopper C, Pammer J, Kloimstein P, Brunner M, Heiduschka G, Grasl MCh, Thurnher D. Multimodal treatment of patients with minor salivary gland cancer in the case of recurrent disease. Head Neck. 2010;32:1167-1172.

7) Woegerbauer M, Thurnher D, Pammer J, Kloimstein P, Brunner M, Heiduschka G, Erovic BM. Expression of the tetraspanins CD9, CD37, CD63, and CD151 in Merkel cell carcinoma: strong evidence for a posttranscriptional fine-tuning of CD9 gene expression. Mod Pathol. 2010;23:751-762.

8) Eder-Czembirek C, Erovic BM, Czembirek C, Brunner M, Selzer E, Pötter R, Thurnher D. Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines. 2010;186:143-148.

9) Brunner M, Erovic BM, Heiduschka G, Thurnher D. RCAS-1 serum and tumor levels in head and neck squamous cell carcinoma. Eur Surg Res. 2010;44:214-219.

2009

10) Heiduschka G, Vormittag L, Erovic BM, Wachek V, Martinek H, Brunner M, Marik W, Ehrenberger K, Thurnher D. Lipophilic 7-beta-Hydroxycholesterol induces apoptosis in squamous cell carcinoma cell lines of the head and neck. Arch Otolaryngology 2009;135:261-267.

11) Vormittag L, Thurnher D, Geleff S, Brannath W, Heiduschka G, Brunner M, Erovic BM. Co-expression of Podoplanin and Bmi-1 in invasive outer cell layers of squamous cell carcinomas of the head and neck identifies cells with epidermal stem cell properties. Int. Journal of Radiation Oncology, Biology, Physics 2009;73:913-918.

12) Brunner M, Thurnher D, Pammer J, Heiduschka G, Kloimstein P, Erovic BM. Expression of hedgehog signalling molecules in Merkel cell carcinoma. 2010;32:333-340.

13) Czembirek C, Eder-Czembirek C, Erovic BM, Thurnher D, Selzer E. The Cyclooxygenase-2 inhibitor Nimesulide induces early but not clonogenic cell death and has no radiosensitizing properties in head and neck cancer cell. Strahlenther Onkol. 2009 185:310-317.

14) Gedlicka C, Item CB, Wögerbauer M, Martinek H, Heiduschka G, Erovic BM, Ch Grasl M, Thurnher D. Transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma of the parotid gland is independent of p53 mutations. J Surg Oncol. 2010;101:127-130.

2008

15) Brunner M, Thurnher D, Pammer J, Geleff S, Erovic BM. Expression of VEGF-R2, Mcl-1 and Bmi-1 in Merkel Cell Carcinoma. Mod Pathol. 2008 21:876-884.

16) Vormittag L, Erovic B, Schopper C, Zielinski CC, Kornek G, Thurnher D. Unilateral face swelling as first manifestation of metastatic pancreatic cancer: Case report and review of the literature. Wien Klin Wochenschr. 2008;120:693-696.

17) Skoda C, Vormittag L, Heiduschka G, Kloimstein P, Eder-Czembirek C, Czembirek C, Erovic BM, Martinek H, Wrba F, Selzer E, Thurnher D. Inhibition of Mcl-1 by antisense technology in squamous cell carcinoma cell lines of the head and neck. Oncol Rep 2008;19:1499-1503.

18) Brunner M, Thurnher D, Brostjan C, Erovic BM. Elevated levels of circulating endothelial progenitor cells in patients with head and neck squamous cell cancer. J Surg Oncol. 2008 1;98:545-550.

19) Arnoldner C, Grasl MCh, Brunner M, Hamzavi JS, Thurnher D, Erovic BM. Postoperative hemorraghe after tonsillectomy: evaluation of 9024 patients during 1993 and 2006 at the Department of Otorhinolaryngology, Vienna, Austria. Wien Klin Wochenschr 2008;120: 336-342.

20) Koehn J, Krapfenbauer K, Huber S, Stein E, Sutter W, Watzinger F, Erovic BM, Thurnher D, Schindler T, Fountoulakis M, Turhani D. Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis. J Proteome Res. 2008;7:3818-3829.

21) Erovic BM, Woegerbauer M, Pammer J, Selzer E, Grasl MCh, Thurnher D. Strong evidence for up-regulation of cyclooxygenase-1 in head and neck cancer. Eur J Clin Invest. 2008;38:61-66.

22) Thurnher D, Erovic BM. Epidemiologie, Ätiologie der HNO Tumoren. Spectrum Onkologie. 2008;2:8-10. Review.

23) Thurnher D, Erovic BM, Pavelka R. Neck dissection. Spectrum Onkologie. 2008;2:25-26. Review.

24) Thurnher D, Erovic BM, Frommlet F, Brannath W, Ehrenberger K, Jansen B, Selzer E, Grasl MCh. Challenging a dogma – surgery yields superior long-term results for T1a squamous cell carcinoma of the glottic larynx compared to radiotherapy. Eur J Surg Oncol. 2008;34:692-698.

2007

25) Stein E, Blaimauer K, Bauer S, Erovic BM, Turhani D, Thurnher D. High expression of Integrin b1 correlates with high proliferation capacity in oral keratinocytes. Accepted Wien Klin Wochenschr 2007;119:318-322.

26) Reinisch CM, Uthman A, Erovic BM, Pammer J. Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions. J Cutan Pathol. 2007;34:174-180.

2006

27) Blaimauer K, Watzinger E, Erovic BM, Martinek H, Jagersberger T, Thurnher D. Effects of epidermal growth factor on the growth of oropharyngeal keratinocytes in co-culture with autologues fibroblasts in a three-dimensional matrix. Cell Tissue Organs 2006;182:98-105.

28) Schulenburg A, Ulrich-Pur H, Thurnher D, Erovic B, Florian S, Sperr WR, Kalhs P, Marian B, Wrba F, Zielinski CC, Valent P. Neoplastic stem cells: a novel therapeutic target in clinical oncology. Cancer. 2006;107:2512-2520.

2005

29) Eder-Czembirek C, Czembirek C, Erovic BM, Selzer E, Turhani D, Vormittag L, Thurnher D. Combination of betulinic acid with cisplatin-different cytotoxic effects in two head and neck cancer cell lines. Oncol Rep. 2005; 14: 667-671.

30) Ulrich-Pur H, Erovic BM, Soleiman A, Jech B, Pennwieser W, Czembirek C, Zielinski CC, Thurnher D. Changes in Mcl-1 expression in rectal cancer in relation to neo-adjuvant radiotherapy. Wien Klin Wochenschr. 2005; 117: 136-140.

31) Erovic BM, Berger U, Neuchrist C, Burian M. Quantitation of microvessel density in squamous cell carcinoma of the head and head by computer image analysis. Wien Klin Wochenschr, 2005;117: 53-57.

32) Lamm W, Vormittag L, Turhani D, Erovic BM, Czembirek C, Eder-Czembirek C, Thurnher D. The effect of nimesulide, a selective cyclooxygenase-2 inhibitor, on Ets-1 and Ets-2 expression in head and neck cancer cell lines. Head Neck. 2005;27:1068-1072.

33) Zeitlinger MA, Erovic BM, Sauermann R, Georgopoulos A, Muller M, Joukhadar C. Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis. J Antimicrob Chemother. 2005; 56: 703-708.

34) Vormittag L, Lamm W, Erovic BM, Czembirek C, Kornek G, Thurnher D. Expression levels of Akt in nimesulide-treated squamous carcinoma cell lines of the head and neck. Oncol Rep. 2005; 13: 207-210.

35) Czembirek C, Eder-Czembirek C, Erovic BM, Turhani D, Selzer E, Thurnher D.  Inhibition of cytotoxicity of cisplatin by cyclooxygenase-2 inhibitor nimesulide in head and neck cancer cell lines. Oncol Rep. 2005; 14:1523-1526.

36) Erovic BM, Pelzmann M, Grasl MCh, Pammer J, Kornek G, Brannath W, Selzer E, Thurnher D. Mcl-1, VEGF-R2 and 14-3-3s expression might predict primary response against radio(-chemo) therapy in patients with locally advanced squamous cell carcinomas of the head and neck. Clinical Cancer Res 2005; 15: 952-956.

2004

37) Kubista B, Erovic BM, Klinger H, Sulzbacher I, Trieb K. CD9 expression is not a prognostic factor in human osteosarcoma. Cancer Lett 2004, 209; 105-110.

2003

38) Erovic BM, Pammer J, Hollemann D, Woegerbauer M, Fischer M, Burian M, Neuchrist C. MRP-1/CD9 expression on squamous cell carcinomas of the head and neck. Head and Neck. 2003; 25:848-857.

39) Erovic BM, Pelzmann M, Turhani D, Niederberger V, Neuchrist C, Grasl MCh, Thurnher D. Differential expression pattern of Cox-1 and Cox-2 in head and neck squamous cell carcinoma. Acta-Otolaryngol 2003;8:950-953.

40) Erovic BM, Neuchrist C, Kandutsch S, Woegerbauer M, Pammer J. CD9 expression on lymphatic vessels in head and mucosa. Modern Pathology. 2003; 16: 1028-1034.

41) Ewers R, Turhani D, Item CB, Kapral D, Thurnher D, Cvikl B, Weissenböck M, Erovic BM, Lauer G. “Bioengineered Knochen—Produktion” – Aktuelle Anwendungen des Tissue Engineering in der Mund-, Kiefer- und Gesichtschirurgie. Z. Zahnärztl Impl 2003; 19: 216-220.

42) Turhani D, Item C, Thurnher D, Kapral D, Cvikl B, Weissenbock M, Yerit K, Erovic B, Moser D, Watzinger F, Ewers R, Lauer G. [Evidence of osteocalcin expression in osteoblast cells of mandibular origin growing on biomaterials with RT-PCR and SDS-PAGE/Western blotting] Mund Kiefer Gesichtschir. 2003;7:294-300.

43) Sauermann R, Zeitlinger M, Erovic BM, Marsik C, Georgopoulos A, Müller M, Brunner M, Joukhadar C. Pharmacodynamics of piperacillin in severly ill patients evaluated by using a PK/PD model International journal of antimicrobial agents, in press, 2003; 22: 574-578.

44) Neuchrist C, Erovic BM, Steiner G, Handisurya A, Gedlicka C, Burian M. VEGF-R3 (FLT-4) expression in squamous cell carcinomas of the head and neck. Head and Neck, 2003; 25:464-474.

45) Hann S, Koellensperger G, Kanitsar K, Stingeder G, Brunner M, Erovic B, Muller M, Reiter C. Platinum determination by inductively coupled plasma sector field spectometry (ICP-SFMS) in different matrices relevant to human biomonitoring. Analytical and Bioanalytical Chemistry, 2003; 376: 198-204.

2002

46) Brunner M, Stabeta H, Möller JG, Schrolnberger C, Erovic BM, Hollenstein U, Zeitlinger M, Eichler HG, Müller M. Target site concentrations of ciprofloxacin after single intravenous and oral doses. Journal of Antimicrobial Chemotherapy, 2002; 46: 3724-3730.

2001

47) Neuchrist C, Erovic BM, Handisurya A, Steiner GE, Rockwell P, Gedlicka C, Burian M. Vascular endothelial growth factor receptor 2 (VEGF-R2) expression in squamous cell carcinomas of the head and neck. Laryngoscope, 2001; 111: 1834-1841.

2000

48) Brunner M, Joukhadar C, Schmid R, Erovic BM, Eichler HG, Müller M. Validation of urea as an endogenous reference-compound for the in vivo calibration of microdialysis probes. Life Sciences 2000; 76: 977-984.

 

49) Hollenstein U, Brunner M, Mayer BX, Delacher S, Erovic BM, Eichler HG, Müller M. Target site concentrations of cefpirome folowing continous infusion and bolus injection in healthy volunteers. Clinical Pharmacology and Therapeutics 2000; 67: 229-236.

50) Frossard M, Joukhadar C, Erovic BM, Dittrich P, Mrass PE, van Houte M, Burgmann H, Georgopoulos A, Müller M. Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. Antimicrobial Agents Chemotherapy 2000;44:2728-2732.

 

Manuskripte in Review

 

1) Kloimstein P, Thurnher D, Schneider S, Pammer J, Brannath W, Brunner W, Grasl MCh, Erovic BM. New diagnostic factors for malignant salivary gland tumors. Cancer.

2) Erovic BM, Mitulovic G, Hallström S, Brannath W, Brunner M, Woegerbauer M, Thurnher D. Transcriptome and Proteome mapping of Nimesulide/Cisplatin-induced Apoptosis in Tumor Cells of the Upper Aerodigestive Tract. Cancer.

3) Erovic BM, Schneider S, Feierabend D, Schopper C, Pammer J, Maleki A, Vormittag L, Brannath W, Grasl MCh, Thurnher D. Bclx predicts overall and disease-free survival in patients with minor salivary gland carcinomas. Head Neck.

4) Erovic BM, Goldstein DP, Kim D, Mete O, Brierley J, Tsang R, Freeman JL, Asa SL, Rotstein L, Irish JC. Schwannoma of the facial nerve: Outcome analysis of 16 patients treated at the Princess Margaret Hospital. Head Neck accepted.

5) Erovic BM, Daly MJ, Chan H, Nithiananthan S, Pothier DD, James AL, Papsin BC, Siewerdsen JH, Irish JC. Utility and accuracy of intraoperative cone-beam CT and optical drill tracking for guidance of temporal bone surgery. Laryngoscope.

6) Erovic BM, Ravi A, Yeung R, Lee JW, Yao C, Enepekides DJ, Higgins KM. Volumetric changes of the anterolateral thigh free flap following adjuvant radiotherapy in total parotidectomy reconstruction. Laryngoscope.

7) Higgins KM, Ashford B, Erovic BM, Yoo J, Enepekides DJ. Temporoparietal fascia free flap for pharyngeal coverage after salvage total laryngectomy. Laryngoscope accepted.

8) Yao C, Erovic BM, Higgins KM. A solitary extramedullary plasmacytoma presenting as a thyroid goiter with a positive Pemberton’s sign in a patient with Hashimoto's Thyroiditis. Thyroid.

9) Erovic ID, Erovic, BM. Merkel cell carcinoma: a review. Histology Histopathology.

10) Grasl MCh, Pokieser P, Gleiss A, Brandstätter J, Sigmund T, Erovic BM, Fischer MR. Overall estimation and effectiveness of a new blended learning concept for medical students in otolaryngology. Arch Otolaryngol.

 

Manuskripte in Vorbereitung

 

1) Blaise C, Erovic BM, Ghazarian D, Al Habeeb. Genetic alterations in sebaceous gland tumors.

2) Al Habeeb A, Erovic, BM, Ghazarian D. Saccharose related protein expression in sebaceous gland tumors.

3) Al Habeeb A, Erovic, BM, Ghazarian D. Molecular alterations in Merkel cell carcinomas.

4) Grewal A, Erovic BM, Enepekides DJ, Higgins KM. Microvascular coupling devices for veins and areteries: meta-analysis.

5) Erovic BM, Ozgur M, Harris L, Goldstein DP, Jamali M, Asa SL, Irish JC. Identification of novel target proteins in parathyroid carcinoma.

6) Erovic BM, Ozgur M, Harris L, Goldstein DP, Jamali M, Gullane P, Asa SL, Irish JC. Protein expression profile of PET-CT scan positive and negative parathyroid adenomas.

7) Erovic BM, Ozgur M, Kim D, Cassol C, Goldstein DP, Asa SL, Irish JC. Identification of novel target proteins in medullary thyroid carcinoma.

8) Erovic BM, Harris L, Goldstein DP, Al Habeeb A, Waldron J, Ghazarian D, Irish JC. Identification of novel target proteins in sebaceous gland carcinoma.

9) Erovic BM, Josephson J, Goldstein DP, Gullane PJ, Brown D, Gilbert RW, Irish JC. FNA accuracy in thyroid nodules.

10) Erovic BM, Shah MD, Goldstein DP, Bruch G, Simpson C, Waldron J, Perez-Ordonez B, Gullane PJ, Brown D, Gilbert RW, Irish JC. Outcome analysis of 271 patients with major salivary gland cancer: The Princess Margaret Hospital experience.

11) Erovic BM, Ozgur M, Harris L, Goldstein DP, Asa SL, Jamali M, Irish JC. Differential expression pattern of tumor antigens in benign versus malignant parathyroid tumors .

12) Erovic BM, Schneider S, Maleki A, Pammer J, Womastek I, Graf A, Grasl MCh. Indian hedgehog expression predicts primary response of patients with locally advanced squamous cell carcinomas of the head and neck to radio(-chemo) therapy: a prospective single institution study.

13) Erovic BM, Daly MJ, Chan H, Yu E, Nithiananthan S, Pothier DD, James AL, Papsin BC, Siewerdsen JH, Irish JC. Comparing CT versus CBCT images of temporal bones: Is there any differences in management outcome?

14) Erovic BM, Pammer J, Grasl MCh. p63 expression in squamous cell carcinomas of the head and neck.

15) Sawka A, Erovic, BM, Goldstein DP. Management of thyroid cancer. CMAJ. Review.


Schlüsselwörter zur klinisch-wissenschaftlichen Expertise

 

1) Definition von diagnostisch/prognostisch/prädiktiven und target Proteine in Kopf-Hals Karzinomen.

2) Behandlungsoptimierung und ´Targeted therapy´ in Merkelzell Karzinomen.

3) Tumoren der Haut

4) Rekonstruktiven Chirurgie


   admin@erovic.at © Boban Erovic 2011